Location History:
- Philadelphia, PA (US) (2016)
- Wilmington, DE (US) (2018 - 2020)
- Glen Mills, PA (US) (2016 - 2022)
Company Filing History:
7 out of 669 
1 out of 2,623 
1 out of 1,210 
Years Active: 2016-2022
Title: **The Innovative Mind of Joel R. Courter**
Introduction
Joel R. Courter, based in Glen Mills, Pennsylvania, is an accomplished inventor with a remarkable track record of nine patents. His contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer, demonstrate his innovative spirit and dedication to improving healthcare.
Latest Patents
Among his latest patents, Courter has developed cyclopropylamine derivatives that function as LSD1 inhibitors. These compounds are aimed at treating diseases such as cancer, showcasing his focus on impactful medical innovations. Additionally, he has patented substituted imidazo[1,2-a]pyrazines, which are also LSD1 inhibitors and are useful in the treatment of various cancers. Both inventions reflect his commitment to addressing critical health challenges through innovative solutions.
Career Highlights
Throughout his career, Joel R. Courter has held various positions in notable companies, including Incyte Corporation. His work there has significantly contributed to advancements in medicinal chemistry and cancer therapeutics, solidifying his reputation in the industry.
Collaborations
In his journey as an inventor, Courter has collaborated with talented individuals such as Liangxing Wu and Chunhong He. These partnerships have fostered an environment of creativity and knowledge exchange, leading to significant advancements in their shared field of research.
Conclusion
Joel R. Courter's impressive portfolio of patents and collaborations marks him as a key figure in the world of pharmaceutical innovation. With his continued efforts, he not only advances scientific research but also plays a crucial role in the development of new treatments that could potentially save lives.